Status: Enrolling
Investigator: Warren Ellsworth
Study Coordinator: Adrienne New
Phone: 713.441.3250
This is a multicenter registry study to collect utilization, safety, and outcomes data from medical record chart review of nerve reconstruction procedures throughout the body with Avance® Nerve Graft. Addendum 1 (MATCH) establishes a comparat ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Beatriz Efron
Phone: 713.363.8890
The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). ... Read more >
Status: Open Not Enrolling
Investigator: Maen Abdelrahim
Study Coordinator: Michelle Guthrie
Phone: 713.441.6564
This dose-escalation study will evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic, and explore antitumor activity of M3541 in combination with fractionated palliative radiotherapy (RT) in subjects with solid tumors with ma ... Read more >
Status: Enrolling
Investigator: Deepa Gotur
Study Coordinator: Alexandra Villanueva
Phone: 713.441.3879
The purpose of this research study is to see how safe and effective the use of Technegas imaging is in lung imaging. Technegas is an investigational aerosol imaging agent that you inhale that makes the lungs show up during a nuclear medicine ven ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label. ... Read more >
Status: Enrolling
Investigator: Aldona Spiegel
Study Coordinator: Adrienne New
Phone: 713.441.3250
This is a multicenter registry study to collect utilization, safety, and outcomes data from medical record chart review of nerve reconstruction procedures throughout the body with Avance® Nerve Graft. Addendum 1 (MATCH) establishes a comparat ... Read more >
Status: Enrolling
Investigator: Monisha Singh
Study Coordinator: Michelle Guthrie
Phone: 713.441.6564
The primary goal of this Phase 1 study is to characterize the safety and tolerability of INCMGA00012 and establish the maximum tolerated dose (MTD) of INCMGA00012 administered on either every two week or every four week schedules of administrati ... Read more >
Status: Enrolling
Investigator: Eamonn Quigley
Study Coordinator: Alejandro De La Torre
Phone: 713.441.6396
The study is a prospective, randomized, multicenter, adaptive design, single blinded, placebo-controlled study, to evaluate the efficacy and safety of Vibrant Capsule vs. placebo in relieving constipation in subjects with Chronic Idiopathic Cons ... Read more >
Status: Open Not Enrolling
Investigator: Maen Abdelrahim
Study Coordinator: Denesha Potts
Phone: 713.441.6011
This is an open-label, phase 2 comparative study to assess the safety, tolerability, and preliminary efficacy of nal-IRI in combination with other anticancer therapies in patients with advanced pancreatic adenocarcinoma who have not received pri ... Read more >
Status: Enrolling
Investigator: David Mobley
Study Coordinator: Brittany Foerster
Phone: 281.276.3053
This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease. ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Beatriz Efron
Phone: 713.363.8890
The purpose of this study is to compare the incidence of lymphoma in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi versus those treated with thiopurines. ... Read more >
Status: Open Not Enrolling
Investigator: Danielle Antosh
Study Coordinator: Alexandra Villanueva
Phone: 713.441.3879
This randomized, double-blind, placebo-controlled, multi-center, confirmatory study will evaluate the efficacy and safety of Cook MyoSite Incorporated Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) compared to a placebo ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Second ... Read more >
Status: Enrolling
Investigator: Monica Morgan
Study Coordinator: Michelle Guthrie
Phone: 713.441.6564
Treatment ... Read more >
Status: Enrolling
Investigator: Marvin Atkins
Study Coordinator: Kim Donlon
Phone: 713.441.9394
This study is a prospective, multicenter, non-randomized single-arm study to assess the feasibility of the treatment of DeBakey Type I/II aortic dissections with the GORE® TAG® Thoracic Branch Endoprosthesis system. ... Read more >
Status: Open Not Enrolling
Investigator: Eric Peden
Study Coordinator: Kim Donlon
Phone: 713.441.9394
This trial will evaluate the safety and efficacy of concentrated bone marrow aspirate (cBMA) to prevent or delay major amputation and/or death in subjects with critical limb ischemia (CLI) due to severe peripheral arterial disease (PAD). ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as compared to a non- Cimzia® control population. The SECURE Registry's target enrollment is 3045 patients and its objective is to monitor patients for ap ... Read more >
Status: Enrolling
Investigator: Rose Khavari
Study Coordinator: Hamida Rajab
Phone: 713.363.9154
Difficulty in bladder emptying (Voiding dysfunction,VD) is a costly urinary condition that leads to urinary tract infections/stones, sepsis, bladder loss, and permanent kidney damage. VD can be present in patients with or without neurologic/brai ... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Patricia Brinegar
Phone: 713.441.3506
The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transca ... Read more >
Status: Enrolling
Investigator: Joshua Swan
Study Coordinator: Elsie Rizk
Phone: 832.946.0487
Ventilated ICU patients frequently have sepsis and the majority have delirium, a form of brain dysfunction that is an independent predictor of increased risk of dying, length of stay, costs, and prolonged cognitive impairment in survivors. Unive ... Read more >
Status: Open Not Enrolling
Investigator: Dale Hamilton
Study Coordinator: Melissa Whipple
Phone: 713.441.3247
UX023T-CL201 is an, open-label, Phase 2 study. The study will be conducted in adults aged 18 years or older with TIO or ENS whose tumor/skin lesion is inoperable to assess the efficacy and safety of KRN23 administered via subcutaneous injections ... Read more >
